Also from this source


Jul 11, 2017, 02:16 ET Orexo Interim Report Q2 2017

You just read:

U.S. FDA Approves Orexo's Low Dose ZUBSOLV® Buprenorphine and Naloxone Sublingual Tablets (CIII)

News provided by

Orexo

Oct 06, 2016, 08:00 ET